For US Healthcare Providers Only
Makena is a progestin indicated to reduce the risk of preterm birth in women with a singleton pregnancy who have a history
We acknowledge there may be some confusion in the healthcare community about the current status of Makena. At this time, it is important to know that Makena’s approval and product label remain unchanged. To learn more about current medical association guidelines, you can visit the American College of Obstetricians and Gynecologists and/or the Society for Maternal-Fetal Medicine website(s).
If you have any questions regarding your patients on or prescribed Makena, please contact Makena Care Connection® at 1-800-847-3418 (M–F, 8AM–8PM ET) or by emailing firstname.lastname@example.org.
©2019 AMAG Pharmaceuticals, Inc. All rights reserved. PP-MKN-US-00578 11/19